Valuation: Boston Scientific Corporation

Market Cap 66.32B 57.97B 53.61B 49.2B 93.11B 6,391B 94.73B 639B 251B 3,121B 249B 244B 10,774B P/E 2026 *
16.4x
P/E 2027 * 15.6x
Enterprise Value 72.88B 63.7B 58.91B 54.06B 102B 7,023B 104B 703B 276B 3,429B 274B 268B 11,840B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 2.99x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day-0.47%
1 week-0.82%
Current month+4.55%
1 month-4.90%
3 months-29.64%
6 months-49.34%
Current year-53.20%
1 week 42.2
Extreme 42.2
45.45
1 month 42.2
Extreme 42.2
46.37
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
7/1/26 A Fiscal year

Chief Financial Officer

5,184 0.0004%
5/28/26 A Don

Chief Executive Officer

-386,755 0.0261%
5/20/26 A Buy

Director

3,580 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+3.67%-0.82%-56.76%-15.86% 66.32B
+1.48%+3.52%+30.48%+2.61% 202B
+2.10%+4.61%+6.06%-14.77% 145B
+3.43%-2.24%-21.52%+13.65% 142B
+0.65%-3.82%+15.37%-5.93% 50.58B
+0.30%+2.60%-23.82%-31.09% 44.81B
+1.03%+1.88%+19.99%+13.65% 38.44B
+0.87%+0.28%+30.61%+39.67% 37.13B
+3.96%+1.55%-12.92%-19.70% 29.89B
+2.11%-2.73%-20.25%-8.81% 29.25B
Average +1.55%+0.67%-3.28%-2.66% 78.59B
Weighted average by Cap. +1.73%+1.63%+1.06%-1.61%

Financials

2026 *2027 *
Net sales 21.57B 18.85B 17.43B 16B 30.28B 2,078B 30.8B 208B 81.67B 1,015B 80.99B 79.21B 3,503B 23.31B 20.37B 18.84B 17.29B 32.72B 2,246B 33.29B 225B 88.26B 1,097B 87.52B 85.6B 3,786B
Net income 3.87B 3.39B 3.13B 2.87B 5.44B 373B 5.53B 37.34B 14.67B 182B 14.54B 14.23B 629B 4.11B 3.59B 3.32B 3.05B 5.77B 396B 5.87B 39.63B 15.57B 193B 15.44B 15.1B 668B
Net Debt 6.56B 5.73B 5.3B 4.86B 9.21B 632B 9.37B 63.22B 24.84B 309B 24.63B 24.09B 1,065B 3.43B 2.99B 2.77B 2.54B 4.81B 330B 4.89B 33.02B 12.97B 161B 12.86B 12.58B 556B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
16/07/26 $44.62 +3.67% 18,783,113
15/07/26 $43.04 +0.96% 14,531,545
14/07/26 $42.63 -4.52% 20,088,275
13/07/26 $44.65 -0.27% 13,165,876
10/07/26 $44.77 -0.49% 12,043,072
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
44.62USD
Average target price
72.43USD
Spread / Average Target
+62.32%

Quarterly revenue - Rate of surprise